David Jonathan Bennett

2.6k total citations · 1 hit paper
24 papers, 865 citations indexed

About

David Jonathan Bennett is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David Jonathan Bennett has authored 24 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in David Jonathan Bennett's work include Drug Transport and Resistance Mechanisms (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Oxidative Organic Chemistry Reactions (3 papers). David Jonathan Bennett is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Cholesterol and Lipid Metabolism (4 papers) and Oxidative Organic Chemistry Reactions (3 papers). David Jonathan Bennett collaborates with scholars based in United Kingdom, United States and Spain. David Jonathan Bennett's co-authors include Xiaoshen Ma, Yongxin Han, David L. Sloman, Nigel S. Simpkins, Charles S. Yeung, Olivia L. Garry, David W. C. MacMillan, Helen Feilden, Andrew Cooke and Edward J. Hutchinson and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Molecular Biology.

In The Last Decade

David Jonathan Bennett

24 papers receiving 843 citations

Hit Papers

General access to cubanes as benzene bioisosteres 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. General access to cubanes as benzene bioisosteres
    2023 108 citations Mario P. Wiesenfeldt, James A. Rossi‐Ashton et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Jonathan Bennett United Kingdom 13 509 216 121 109 106 24 865
Gary J. Tarver United Kingdom 12 365 0.7× 218 1.0× 38 0.3× 130 1.2× 55 0.5× 15 725
Jeffery S. Carter United States 7 711 1.4× 153 0.7× 33 0.3× 26 0.2× 51 0.5× 7 997
Carmen Almansa Spain 22 705 1.4× 578 2.7× 51 0.4× 8 0.1× 32 0.3× 51 1.4k
Carsten Schmeck Germany 15 312 0.6× 309 1.4× 43 0.4× 2 0.0× 69 0.7× 26 759
J. A. Miller United States 18 202 0.4× 243 1.1× 26 0.2× 12 0.1× 24 0.2× 51 708
Vinita Uttamsingh United States 11 43 0.1× 219 1.0× 60 0.5× 8 0.1× 13 0.1× 18 562
Michael Foreman United Kingdom 10 412 0.8× 151 0.7× 87 0.7× 6 0.1× 9 0.1× 33 742
Dirk Van Haver Belgium 15 288 0.6× 183 0.8× 75 0.6× 4 0.0× 8 0.1× 45 668
Paul W. Collins United States 11 418 0.8× 140 0.6× 27 0.2× 7 0.1× 20 0.2× 19 648
Ralf Plate Netherlands 15 291 0.6× 250 1.2× 17 0.1× 7 0.1× 18 0.2× 47 586

Countries citing papers authored by David Jonathan Bennett

Since Specialization
Citations

This map shows the geographic impact of David Jonathan Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jonathan Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jonathan Bennett more than expected).

Fields of papers citing papers by David Jonathan Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jonathan Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jonathan Bennett. The network helps show where David Jonathan Bennett may publish in the future.

Co-authorship network of co-authors of David Jonathan Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of David Jonathan Bennett. A scholar is included among the top collaborators of David Jonathan Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jonathan Bennett. David Jonathan Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valero, Teresa, Álvaro Lorente‐Macías, David Jonathan Bennett, et al.. (2023). Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells. RSC Medicinal Chemistry. 14(12). 2611–2624. 2 indexed citations
2.
Wiesenfeldt, Mario P., James A. Rossi‐Ashton, Ian B. Perry, et al.. (2023). General access to cubanes as benzene bioisosteres. Nature. 618(7965). 513–518. 108 indexed citations breakdown →
3.
Garry, Olivia L., Yufan Liang, Xiaheng Zhang, et al.. (2023). Rapid Access to 2-Substituted Bicyclo[1.1.1]pentanes. Journal of the American Chemical Society. 145(5). 3092–3100. 79 indexed citations
4.
Vara, Brandon, Samuel M. Levi, David A. Candito, et al.. (2021). Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds. ACS Medicinal Chemistry Letters. 12(4). 653–661. 31 indexed citations
5.
Yu, Wensheng, Yongqi Deng, David L. Sloman, et al.. (2021). Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold. Bioorganic & Medicinal Chemistry Letters. 49. 128314–128314. 6 indexed citations
6.
Ali, Amjad, Scott B. Hoyt, Yusheng Xiong, et al.. (2016). Imidazopyridyl compounds as aldosterone synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(2). 143–146. 8 indexed citations
7.
Baugh, Mark, David Jonathan Bennett, Jiaqiang Cai, et al.. (2010). 1H-Imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: Separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka. Bioorganic & Medicinal Chemistry Letters. 21(3). 932–935. 6 indexed citations
8.
Cai, Jiaqiang, Xavier Fradera, David Jonathan Bennett, et al.. (2010). 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important. Bioorganic & Medicinal Chemistry Letters. 20(15). 4507–4510. 16 indexed citations
9.
Fradera, Xavier, Olaf Nimz, R.J. Skene, et al.. (2010). X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer Signaling. Journal of Molecular Biology. 399(1). 120–132. 51 indexed citations
10.
Bennett, David Jonathan, Andrew Cooke, & Andrew J. Edwards. (2006). Non-Steroidal LXR Agonists; An Emerging Therapeutic Strategy for the Treatment of Atherosclerosis. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery). 1(1). 21–46. 20 indexed citations
11.
Bennett, David Jonathan, et al.. (2006). An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis. Expert Opinion on Therapeutic Patents. 16(12). 1673–1699. 8 indexed citations
12.
Bennett, David Jonathan, et al.. (2004). A novel asymmetric route to succinimides and derived compounds: synthesis of the lignan lactone (+)-hinokinin. Chemical Communications. 1392–1392. 40 indexed citations
13.
Bennett, David Jonathan, Alexander J. Blake, Paul Cooke, et al.. (2004). Stereoselectivity in reactions of atropisomeric lactams and imides. Tetrahedron. 60(20). 4491–4511. 45 indexed citations
14.
Bennett, David Jonathan, et al.. (2004). Liver X receptor agonists as a treatment for atherosclerosis. Expert Opinion on Therapeutic Patents. 14(7). 967–982. 5 indexed citations
15.
Bennett, David Jonathan, Andrew Cooke, Niall M. Hamilton, et al.. (2003). Novel water soluble 2,6-dimethoxyphenyl ester derivatives with intravenous anaesthetic activity. Bioorganic & Medicinal Chemistry Letters. 13(12). 1971–1975. 8 indexed citations
16.
Bennett, David Jonathan, et al.. (2003). Novel Water Soluble 2,6‐Dimethoxyphenyl Ester Derivatives with Intravenous Anaesthetic Activity.. ChemInform. 34(38). 4 indexed citations
17.
Adam, Julia M., David Jonathan Bennett, A. Bom, et al.. (2002). Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide:  Synthesis and Structure−Activity Relationships. Journal of Medicinal Chemistry. 45(9). 1806–1816. 190 indexed citations
18.
Belelli, Delia, David Jonathan Bennett, Anna Casula, et al.. (2001). α-Amino Acid Phenolic Ester Derivatives:  Novel Water-Soluble General Anesthetic Agents Which Allosterically Modulate GABAA Receptors. Journal of Medicinal Chemistry. 44(22). 3582–3591. 23 indexed citations
19.
Bennett, David Jonathan, et al.. (2001). Enantiospecific enzyme-catalysed resolution of novel N,N-disubstituted α-amino acid phenolic ester derivatives using pig liver esterase. Journal of the Chemical Society Perkin Transactions 1. 362–365. 2 indexed citations
20.
Bennett, David Jonathan, et al.. (1980). Spirans. Part 12. Stereochemical control in the oxidative cyclisation of bisnaphthols. Journal of the Chemical Society Perkin Transactions 1. 1978–1978. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary J. Tarver Breakdown of academic impact, for papers by Jeffery S. Carter Breakdown of academic impact, for papers by Carmen Almansa Breakdown of academic impact, for papers by Carsten Schmeck Breakdown of academic impact, for papers by J. A. Miller Breakdown of academic impact, for papers by Vinita Uttamsingh Breakdown of academic impact, for papers by Michael Foreman Breakdown of academic impact, for papers by Dirk Van Haver Breakdown of academic impact, for papers by Paul W. Collins Breakdown of academic impact, for papers by Ralf Plate
Rankless by CCL
2026